Citation Impact

Citing Papers

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
The ISHAGE Guidelines for CD34+ Cell Determination by Flow Cytometry
1996 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
1998
Dose Intensification of Etoposide in the BEAM ABMT Protocol for Malignant Lymphoma
1995
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
1996
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992
Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy
1995
Paclitaxel-induced neuropathy
1995
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Causes and consequences of aneuploidy in cancer
2012
Expression of Functional Markers in Acute Nonlymphoblastic Leukemia
2000
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Determinants of urinary 8‐hydroxy‐2′‐deoxyguanosine in Chinese children with acute leukemia
2008
A Comparison of Cyclophosphamide and Total Body Irradiation with Etoposide and Total Body Irradiation as Conditioning Regimens for Patients Undergoing Sibling Allografting for Acute Lymphoblastic Leukemia in First or Second Complete Remission
2006
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.
1993
Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta
2002
Diffuse large B-cell lymphoma
2013
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis
2009 Standout
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Myeloid Leukemia in Children: An Evidence-Based Review
2007
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Bone Marrow Transplants from HLA-Identical Siblings as Compared with Chemotherapy for Children with Acute Lymphoblastic Leukemia in a Second Remission
1994
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Mitoxantrone, Etoposide, and Cyclosporine Therapy in Pediatric Patients With Recurrent or Refractory Acute Myeloid Leukemia
2000
Gene correction in hematopoietic progenitor cells by homologous recombination
2000 StandoutNobel
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy
1993
Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
1989
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
1990
Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
1998
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Risk assessment in haematopoietic stem cell transplantation: Conditioning
2007
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout

Works of DC Shina being referenced

The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation
1990
Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation
1989
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission
1988
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.
1993
Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
1996
Rankless by CCL
2026